Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESULT: Low-volume vs Intermediate-volume Bowel Preparation
NCT05242562Completed
- Sponsor
- Radboud University Medical Center
- Start
- May 2022
- Primary completion
- Feb 2023
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
Randomised, open-label trial of polyethylene glycol + electrolytes + ascorbic acid in colorectal cancer (CRC) and colonic polyp (2 arms), sponsored by Radboud University Medical Center. Primary endpoints: Boston Bowel Preparation Scale and Proportion of adequately prepared patients. Started May 2022; status: completed.
02
Drugs
polyethylene glycol + electrolytes + ascorbic acid
03
Conditions
colorectal cancer (CRC)colonic polyp
Beyond the preview
Go deeper on NCT05242562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05242562.